Bendell JC - Search Results

1

First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors.

Forero A, Bendell JC, Kumar P, Janisch L, Rosen M, Wang Q, Copigneaux C, Desai M, Senaldi G, Maitland ML. Forero A, et al. Among authors: bendell jc. Invest New Drugs. 2017 Jun;35(3):298-306. doi: 10.1007/s10637-016-0420-1. Epub 2017 Jan 3. Invest New Drugs. 2017. PMID: 28050790 Clinical Trial.

2

A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.

Jones SF, Bendell JC, Infante JR, Spigel DR, Thompson DS, Yardley DA, Greco FA, Murphy PB, Burris HA 3rd. Jones SF, et al. Among authors: bendell jc. Clin Adv Hematol Oncol. 2011 Mar;9(3):225-30. Clin Adv Hematol Oncol. 2011. PMID: 21475129 Clinical Trial.

3

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Bendell JC, Rodon J, Burris HA, de Jonge M, Verweij J, Birle D, Demanse D, De Buck SS, Ru QC, Peters M, Goldbrunner M, Baselga J. Bendell JC, et al. J Clin Oncol. 2012 Jan 20;30(3):282-90. doi: 10.1200/JCO.2011.36.1360. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162589 Clinical Trial.

4

A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors.

Jones SF, Infante JR, Thompson DS, Mohyuddin A, Bendell JC, Yardley DA, Burris HA 3rd. Jones SF, et al. Among authors: bendell jc. Cancer Chemother Pharmacol. 2012 Sep;70(3):471-5. doi: 10.1007/s00280-012-1931-x. Epub 2012 Aug 1. Cancer Chemother Pharmacol. 2012. PMID: 22851205 Clinical Trial.

5

Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors.

Infante JR, Keedy VL, Jones SF, Zamboni WC, Chan E, Bendell JC, Lee W, Wu H, Ikeda S, Kodaira H, Rothenberg ML, Burris HA 3rd. Infante JR, et al. Among authors: bendell jc. Cancer Chemother Pharmacol. 2012 Nov;70(5):699-705. doi: 10.1007/s00280-012-1960-5. Epub 2012 Sep 2. Cancer Chemother Pharmacol. 2012. PMID: 22941375 Clinical Trial.

6

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.

Infante JR, Novello S, Ma WW, Dy GK, Bendell JC, Huff A, Wang Q, Suttle AB, Allen R, Xu CF, Ottesen LH, Burris HA 3rd, Adjei AA. Infante JR, et al. Among authors: bendell jc. Invest New Drugs. 2013 Aug;31(4):927-36. doi: 10.1007/s10637-012-9900-0. Epub 2012 Nov 22. Invest New Drugs. 2013. PMID: 23179337 Clinical Trial.

7

Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer.

Infante JR, Bendell JC, Goff LW, Jones SF, Chan E, Sudo T, Burris HA, Berlin JD. Infante JR, et al. Among authors: bendell jc. Eur J Cancer. 2013 Apr;49(6):1169-75. doi: 10.1016/j.ejca.2012.11.033. Epub 2013 Jan 5. Eur J Cancer. 2013. PMID: 23294608 Clinical Trial.

8

A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors.

Pant S, Burris HA 3rd, Moore K, Bendell JC, Kurkjian C, Jones SF, Moreno O, Kuhn JG, McMeekin S, Infante JR. Pant S, et al. Among authors: bendell jc. Invest New Drugs. 2014 Feb;32(1):87-93. doi: 10.1007/s10637-013-9949-4. Epub 2013 Mar 24. Invest New Drugs. 2014. PMID: 23525756 Free PMC article. Clinical Trial.

9

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Rodon J, Braña I, Siu LL, De Jonge MJ, Homji N, Mills D, Di Tomaso E, Sarr C, Trandafir L, Massacesi C, Eskens F, Bendell JC. Rodon J, et al. Among authors: bendell jc. Invest New Drugs. 2014 Aug;32(4):670-81. doi: 10.1007/s10637-014-0082-9. Epub 2014 Mar 21. Invest New Drugs. 2014. PMID: 24652201 Clinical Trial.

10

Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.

Bendell JC, Lenz HJ, Ryan T, El-Rayes BF, Marshall JL, Modiano MR, Hart LL, Kingsley CD, George TJ, Nakashima D, Berlin JD. Bendell JC, et al. Invest New Drugs. 2014 Aug;32(4):682-90. doi: 10.1007/s10637-014-0088-3. Epub 2014 Apr 3. Invest New Drugs. 2014. PMID: 24691674 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters